18. 脊髄小脳変性症（多系統萎縮症を除く。） Spinocerebellar degeneration Clinical trials / Disease details

臨床試験数 : 76 / 薬物数 : 98 - (DrugBank : 31) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 65

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01965327 (ClinicalTrials.gov)	August 2013	27/8/2013	Interferon Gamma-1b in Friedreich Ataxia (FRDA)	Open-label Pilot Study of Interferon Gamma-1b(Actimmune™) for the Treatment of Friedreich Ataxia (FR ...	Friedreich Ataxia	Drug: Interferon Gamma -1b	Children's Hospital of Philadelphia	Friedreich's Ataxia Research Alliance;Vidara Therapeutics Research Ltd	Completed	5 Years	17 Years	All	12	Phase 2	United States
2	EUCTR2012-001881-14-IT (EUCTR)	01/03/2013	11/01/2013	A phase II clinical trial to evaluate the safety and efficacy of interferon gamma in elevating frata ...	A phase II clinical trial to evaluate the safety and efficacy of interferon gamma in elevating frata ...	Friedreich's Ataxia MedDRA version: 14.1;Level: SOC;Classification code 10029205;Term: Nervous syste ...	Trade Name: IMUKIN*SC 6F 0,5ML 100MCG INN or Proposed INN: INTERFERON GAMMA -1B	AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2	Italy

First Previous1Next Last